Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy

Published:2018-07 Issue:4 Volume:4 Page:485-493
ISSN:2405-4569
Container-title:European Urology Focus
language:en
Short-container-title:European Urology Focus

Author:

Rentsch Cyrill A.,Derré Laurent^ORCID,Dugas Sarah G.,Wetterauer Christian,Federer-Gsponer Joël R.,Thalmann George N.,Ingersoll Molly A.^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference93 articles.

1. The mechanism of action of BCG therapy for bladder cancer—a current perspective;Redelman-Sidi;Nat Rev Urol,2014

2. Mechanisms of BCG immunotherapy and its outlook for bladder cancer;Pettenati;Nat Rev Urol,2018

3. Intravesical therapy for the treatment of nonmuscle invasive bladder cancer: a systematic review and meta-analysis;Chou;J Urol,2017

4. Bacillus Calmette-Guerin therapy alters the progression of superficial bladder cancer;Herr;J Clin Oncol,1988

5. Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteogenomic characterization of the non-muscle-invasive bladder cancer response to BCG reveals potential therapeutic strategies;2024-03-06

2. Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies;PLOS ONE;2023-01-20

3. A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14;European Urology Oncology;2022-04

4. Epigenetic changes related to glucose metabolism in type 1 diabetes after BCG vaccinations: A vital role for KDM2B;Vaccine;2021-04

5. Benefits of BCG‐induced metabolic switch from oxidative phosphorylation to aerobic glycolysis in autoimmune and nervous system diseases;Journal of Internal Medicine;2020-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3